Friday, September 24, 2021
wellness India Expo
Home Tags CDRI

Tag: CDRI

New drug for coronary diseases could be in offing

An agreement between CSIR-CDRI and Marc Laboratories could pave the way for developing a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen-induced platelet aggregation....................

CSIR-CDRI, Lucknow celebrates its 70th annual day

CSIR-CDRI has championed the cause of affordable drugs and has given the world breakthrough molecules like Centchroman and Arteether, says Dr Harsh Vardhan, Union S&T Minister......................

CDRI invites Indian scientists to apply for its ‘Excellence in Drug...

There are two separate individual awards each in the area of Chemical and Life Sciences. Each award carries a cash prize of Rs 20,000/- and a citation...............

CSIR-CDRI & Cipla Foundation partner for a one-of-its-kind research & outreach...

Putting into action, the recent GOI’s provision for CSR funding to support research...................

Dr Ritu Trivedi honored with NASI-Reliance Platinum Jubilee Award 2020 in...

CSIR-CDRI scientist, Dr Ritu Trivedi's work has led to potential products from natural resources and small molecules for the improvement of bone health............................

Society of Biological Chemists (India) honors CSIR-CDRI scientist, Dr Susanta Kar...

The Society of Biological Chemists (India) has chosen Dr Susanta Kar, Senior Scientist, Molecular Parasitology and Immunology, CSIR-CDRI, Lucknow for this year's Prof. A N Bhaduri Memorial Lecture Award.....................

CSIR-CDRI scientist, Dr Saman Habib elected as fellow of INSA, New...

With this honor, Dr Habib has bagged fellowship of all three premier Science Academies of India...........................

CSIR-CDRI felicitates young researchers for their contribution in drug discovery

Dr Bushra Ateeq, Dr Surajit Ghosh and Dr Ravi Manjithaya received the Prestigious CDRI Award 2020 for their outstanding contribution in unfolding the knot of cancer...............

CSIR-CDRI conducts serological testing for antibodies against SARS-CoV-2

CSIR-CDRI is carrying out a research study that involves testing of people for antibodies against SARS-CoV-2. The serological testing was conducted from 9th-11th September.........................

CSIR-CDRI’s COVID-19 drug candidate Umifenovir secures DCGI approval for phase III...

This drug has a good safety profile and acts by preventing the entry of virus into human cells and also by priming the immune system......................